1. Skip to content
Posted on

Doctors Can Refer to Online Document for Chemotherapy Guidelines for Mesothelioma Patients

The 2012 edition of ‘The Elsevier Guide to Oncology Drugs and Regimens’ has been released and is available online on OncologyStat.com.  The completely revised and updated document contains nearly 300 drug regimens commonly used in the treatment of 26 cancer types.  For physicians looking for an appropriate treatment for mesothelioma patients, this document offers detailed information for individual chemotherapy drugs as well as combination treatments.

Pleural mesothelioma, a form of lung cancer caused by asbestos exposure, is often treated with chemotherapy.  In fact, chemotherapy is considered the most effective single modality for the treatment of mesothelioma.  The combination of gemcitabine and cisplatin is one of the most common chemotherapy treatments for mesothelioma patients; however, personalized treatment can lead a mesothelioma specialist to prescribe another regimen.

The Elsevier Guide offers users the option to search for treatments by drug name or by cancer.  For each drug, all combination regimens are also presented.  The details under each chemotherapy regimen include:  what the regimen is used for, biomarker testing recommendations, regimen details including cycle details, references with links to journal articles, and supportive therapy recommendations.

Under the combination of gemcitabine/cisplatin, for example, users can find options for 21- or 28-day-cycle regimens, four references to articles on the combination therapy, as well as recommendations for treating nausea and vomiting, anemia, neutropenia peripheral neuropathy and other side-effects.

The document is available to all registered users of OncologyStat.  OncologyStat is run under a mission “to promote state-of-the-art cancer care by providing oncology professionals with instant online access to the highest-quality news, expert opinion, and clinical information.”

Close to 3,000 Americans are diagnosed with mesothelioma each year.  The cancer is highly aggressive and is resistant to many cancer treatments making it a difficult disease to treat effectively.  There is no known cure for the disease.

More articles by

Nancy Meredith is a blog and web content writer with more than 20 years of professional experience in the Information Technology industry. She has been writing about Mesothelioma for 7 years. Follow Nancy on Google+

Comments are closed.